October 14, 2010 — The US Food and Drug Administration (FDA) has granted humanitarian use device designation for a diaphragm pacing system (NeuRx; Synapse Biomedical, Inc) in patients with amyotrophic ...
Synapse Biomedical Inc. has won breakthrough device designation from the FDA for its Transaeris system, a diaphragm pacing system (DPS) for use in weaning patients off mechanical ventilation. The ...
TransAeris® Diaphragm Pacing System (DPS) Could Cut Mechanical Ventilation Time by More Than 25%, Freeing up Vital Equipment, ICU Beds and Clinical Resources. OBERLIN, Ohio, April 15, 2020 /PRNewswire ...
ALS patients using diaphragm pacing experienced improved quality of life, with better sleep and daytime functioning, better breathing, and less fatigue. Respiratory failure is one of the major ...
Diaphragmatic pacing is a treatment that improves breathing for people who rely on a mechanical ventilator. It stimulates the phrenic nerve, the nerve in your neck that sends signals to your diaphragm ...
CLEVELAND — Medical technology that was created in Cleveland has been given emergency approval by the FDA to help patients wean off ventilators. Oberlin-based Synapse Biomedical, working with ...
Synapse Biomedical Inc. has won breakthrough device designation from the FDA for its Transaeris system, a diaphragm pacing system (DPS) for use in weaning patients off mechanical ventilation. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results